Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2003
10/02/2003US20030185831 Methods of treating cancer using an FPT inhibitor and antineoplastic
10/02/2003US20030185830 Compositions and methods for the therapy and diagnosis of prostate cancer
10/02/2003US20030185823 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185818 Humanized antibody against cd18
10/02/2003US20030185816 Modified immunogenic self-protein and a surfactant capable of acting as a solubiliser, especially modified human TNF alpha and cetylpyridinium chloride
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185810 Tumor radiosensitization using gene therapy
10/02/2003US20030185808 Prostate cell lines
10/02/2003US20030185802 DNA construct operably encoding a vascular endothelial growth factor receptor protein.
10/02/2003US20030185800 Human interferon-epsilon: a type I interferon
10/02/2003US20030185793 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same
10/02/2003US20030185788 Guanidinium moieties that are either contiguous or spaced along a polymeric backbone, but are sufficiently removed from the backbone via tethers, to allow their interaction with a cell or tissue surface
10/02/2003US20030185761 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/02/2003US20030185756 Carbocyanine dye for visualization, photosensitizer for photodynamic treatment, and tumor receptor-avid peptide for site-specific delivery of the probe and phototoxic agent to diseased tissues
10/02/2003CA2761440A1 Fredericamycin derivatives
10/02/2003CA2756798A1 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/02/2003CA2480384A1 Phenanthridinones as parp inhibitors
10/02/2003CA2480335A1 Combined use of antitumor indolopyrrolocarbazole derivative and other antitumor agent
10/02/2003CA2480302A1 Compositions and methods for treating and preventing necrosis
10/02/2003CA2480099A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003CA2480034A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003CA2479908A1 Calcineurin activator
10/02/2003CA2479887A1 Piperidine or 8-aza-bicyclo¬3.2.1|oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
10/02/2003CA2479881A1 Hif hydroxylase inhibitors
10/02/2003CA2479732A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003CA2479731A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003CA2479730A1 Novel compositions and methods in cancer
10/02/2003CA2479727A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003CA2479723A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003CA2479722A1 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003CA2479721A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003CA2479719A1 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003CA2479671A1 Combination of an aldosterone receptor antagonist and nicotinic acid for a nicotinic acid derivative
10/02/2003CA2479528A1 Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
10/02/2003CA2479306A1 Egfr ligands and methods of use
10/02/2003CA2479288A1 Process for producing cytotoxic lymphocyte
10/02/2003CA2479259A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
10/02/2003CA2478913A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2478330A1 Intraductal management of breast lesions involving therapeutic or diagnostic agents
10/02/2003CA2478063A1 Lymphatic and blood endothelial cell genes
10/02/2003CA2477651A1 Kinase inhibitors
10/01/2003EP1348715A2 CD19xCD3 specific polypeptides and uses thereof
10/01/2003EP1348707A1 Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/01/2003EP1348706A1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
10/01/2003EP1348701A1 (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
10/01/2003EP1348441A1 Topical anti-cancer compositions
10/01/2003EP1348434A1 Use of pyridyl amides as inhibitors of angiogenesis
10/01/2003EP1348433A1 Thiazol-2-yl-imine compounds as PDE-7 inhibitors
10/01/2003EP1348431A1 Process for producing nanoparticles of paclitaxel and albumin
10/01/2003EP1348430A1 Improved paclitaxel-based antitumor formulation
10/01/2003EP1348033A2 Reagents and methods for identifying and modulating expression of genes regulated by retinoids
10/01/2003EP1348022A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/01/2003EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid
10/01/2003EP1347984A2 A process for the preparation of taxan derivatives
10/01/2003EP1347976A2 Tricyclic purine compounds and their analogs as inhibiotrs of cytokine signalling
10/01/2003EP1347973A1 Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors
10/01/2003EP1347972A1 Pyrazolo 3,4-c]pyridines as gsk-3 inhibitors
10/01/2003EP1347971A1 Thiazolyl inhibitors of tec family tyrosine kinases
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/01/2003EP1347959A1 Indole derivatives as ligands of thyroid receptors
10/01/2003EP1347958A1 Process for preparing distamycin derivatives
10/01/2003EP1347805A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body
10/01/2003EP1347783A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units
10/01/2003EP1347780A1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides
10/01/2003EP1347776A2 Anti-inflammatory use of polycationic compounds
10/01/2003EP1347775A2 Uses for polycationic compounds as vaccine adjuvants
10/01/2003EP1347773A2 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
10/01/2003EP1347771A2 Methods of using imxp-888 and imxp-888 antagonists
10/01/2003EP1347769A2 Cancer preventative effect of morinda citrifolia
10/01/2003EP1347762A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
10/01/2003EP1347761A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/01/2003EP1347755A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
10/01/2003EP1347752A2 Anti-proliferative drugs
10/01/2003EP1347751A2 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists
10/01/2003EP1347730A2 Recombinant anti-cd30 antibodies and uses thereof
10/01/2003EP1204655B1 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
10/01/2003EP1100830B1 Heterominibodies
10/01/2003EP1071665B1 Substituted indolinones having an inhibiting effect on kinases and cycline/cdk complexes
10/01/2003EP1019434B1 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis
10/01/2003EP0998473B1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
10/01/2003EP0998455B1 Dihomo-seco-cholestanes with two unsaturated bonds in the side chain
10/01/2003EP0914043B1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
10/01/2003EP0891331B1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity
10/01/2003EP0863917B1 Targeted cytotoxic anthracycline analogs
10/01/2003EP0783511B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446229A Somatostatin analogues
10/01/2003CN1446225A 5'-deoxy-N-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients
10/01/2003CN1446218A Benzimidazole derivatives, preparation method and therapeutic use thereof
10/01/2003CN1446214A Cinnoline compounds
10/01/2003CN1446212A Quinoline derivatives having VEGF inhibiting activity
10/01/2003CN1446197A Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
10/01/2003CN1446106A Method of treating estrogen receptor positive carcinoma
10/01/2003CN1446104A Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
10/01/2003CN1446098A Modulation of alpha-6 integrin-mediated responses
10/01/2003CN1446094A Method for obtaining antigenic structures enhancing specific cross reactivity
10/01/2003CN1446086A Use of estramustine phosphate in treatment of bone metastasis
1 ... 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 ... 2211